BioMed Research International

Diagnostic and Interventional Radiology for Liver Diseases


Status
Published

Lead Editor

1Department of Radiology, Nippon Medical School, Tokyo, Japan

2The Intervention Centre, Oslo University Hospital Rikshospitalet, Oslo, Norway

3Department of Radiology Diakoniekrankenhaus Mannheim, Mannheim, Germany

4Department of Radiology, Toho University, Omori Medical Center, Tokyo, Japan

5Department of Radiological Sciences, UCLA School of Medicine, Los Angeles, USA


Diagnostic and Interventional Radiology for Liver Diseases

Description

The liver is the largest solid organ in the abdomen; therefore, there has been extensive focus on the development and use of new techniques for imaging this organ, especially in this decade. Each imaging modality developed should be able to ascertain the morphology, circulation, metabolism, parenchymal texture, fibrosis, and/or tumor viability in the liver. Moreover, these advanced imaging techniques and other interventional radiology (IR) devices have enabled the development of novel multimodal treatments for imaging the liver, which have yielded promising outcomes in many patients who cannot be surgically treated.

We invite researchers and authors to contribute original research as well as review articles that will support the continuing efforts to understand the diagnostic and interventional radiological aspects of liver diseases such as liver cancer, chronic hepatitis, portal hypertension, and congenital disorders. We are particularly interested in articles describing new modalities and protocols, for example, magnetic resonance (MR) perfusion, MR elastography, and dual-energy computed tomography (CT), which can potentially be used to evaluate liver functions. Contributions on epoch-making IR therapies for liver cancers or portal hypertension are also welcome. Potential topics include, but are not limited to:

  • Recently developed imaging modalities for various liver diseases
  • Advances in equipment and protocols to evaluate fibrosis or hepatitis
  • Latest functional MRI techniques for the liver
  • Role of dual-energy CT in chronic liver diseases and liver cancers
  • Role of nuclear medicine in chronic liver diseases and liver cancers
  • Analysis of hepatocellular carcinoma using EOB-MRI and/or SPIO-MRI
  • Epoch-making IR therapies for unresectable liver cancers including hepatocellular carcinoma, cholangiocarcinoma, and metastasis
  • Novel drug delivery systems for transarterial chemotherapy
  • Current and new techniques to treat portal hypertension including embolization of portosystemic shunts and TIPS

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/radiology/dira/ according to the following timetable:

BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision128 days
Acceptance to publication21 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.